Zeynep Aktas is a San Antonio, Texas based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Zeynep Aktas is FTL48540 for Ophthalmology in Texas. Zeynep Aktas is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Zeynep Aktas speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD, PROFESSOR
Gender:
Female
Practice Address:
4502 Medical Dr, San Antonio, Texas, 78229-4402
Phone:
210-567-0407
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1437956380
NPI Enumeration Date:
27 Feb, 2025
NPI Last Update On:
12 Mar, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Zeynep Aktas are as mentioned below.
License Number
Specialization
State
Status
FTL48540
Ophthalmology
Texas
Primary
FTL48540
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4502 Medical Dr, San Antonio, Texas
Zip:
78229-4402
Phone Number:
210-567-0407
Fax Number:
--
Patients can reach Zeynep Aktas at 4502 Medical Dr, San Antonio, Texas or can call to book an appointment on 210-567-0407. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.